Terms: = Breast cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin AND Treatment
65 results:
1. Phytochemical Profiling by UHPLC-Q-TOF/MS and Chemopreventive Effect of Aqueous Extract of
Rojas-Armas JP; Palomino-Pacheco M; Arroyo-Acevedo JL; Ortiz-Sánchez JM; Justil-Guerrero HJ; Martínez-Heredia JT; Castro-Luna A; Rodríguez Flores C; Guzmán Duxtan AJ
Molecules; 2024 Mar; 29(6):. PubMed ID: 38543016
[No Abstract] [Full Text] [Related]
2. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
3. Jackfruit waste: an invented anticancer therapy using Jacalin lectin from jackfruit seed.
Ghosh P; K M M; Pandey N; Basavan D
Anticancer Drugs; 2023 Nov; 34(10):1085-1093. PubMed ID: 37823283
[TBL] [Abstract] [Full Text] [Related]
4. The direct medical cost of breast cancer management in a provincial hospital of Papua New Guinea: A cost of illness study of consecutive patients from 2017 to 2022.
Umo I; Kulai M; Umo P; James K; Ikasa R
J Cancer Policy; 2023 Dec; 38():100447. PubMed ID: 37813161
[TBL] [Abstract] [Full Text] [Related]
5.
Cho CY; Kang SH; Kim BC; Kim TK; Kim JH; Kim M; Sohn Y; Jung HS
Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37594079
[TBL] [Abstract] [Full Text] [Related]
6. Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects.
Diringer MC; Coliat P; Mathieu C; Laurent N; Mura C; Banerjee M; Zhu C; Grabowska A; Ritchie A; Clarke P; Bernard A; Vit C; Burckel H; Noel G; Harvey P; Pivot X; Detappe A
Small; 2023 Mar; 19(12):e2205961. PubMed ID: 36587987
[TBL] [Abstract] [Full Text] [Related]
7. Zinc-finger protein CXXC5 promotes breast carcinogenesis by regulating the tsc1/mTOR signaling pathway.
Wang W; Zhang Z; Zhao M; Wang Y; Ge Y; Shan L
J Biol Chem; 2023 Jan; 299(1):102812. PubMed ID: 36539038
[TBL] [Abstract] [Full Text] [Related]
8. Fish Oil and Selenium with Doxorubicin Modulates Expression of Fatty Acid Receptors and Selenoproteins, and Targets Multiple Anti-cancer Signaling in Triple-negative breast cancer Tumors.
Guo CH; Shih MY; Chung CH; Lin YC; Fan CT; Peng CL; Chen PC; Hsia S
Int J Med Sci; 2022; 19(14):2044-2057. PubMed ID: 36483592
[TBL] [Abstract] [Full Text] [Related]
9. AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors.
Dunn S; Eberlein C; Yu J; Gris-Oliver A; Ong SH; Yelland U; Cureton N; Staniszewska A; McEwen R; Fox M; Pilling J; Hopcroft P; Coker EA; Jaaks P; Garnett MJ; Isherwood B; Serra V; Davies BR; Barry ST; Lynch JT; Yusa K
Oncogene; 2022 Nov; 41(46):5046-5060. PubMed ID: 36241868
[TBL] [Abstract] [Full Text] [Related]
10. Documenting patients' and providers' preferences when proposing a randomized controlled trial: a qualitative exploration.
Oberoi D; Kwok C; Li Y; Railton C; Horsman S; Reynolds K; Joy AA; King KM; Lupichuk SM; Speca M; Culos-Reed N; Carlson LE; Giese-Davis J
BMC Med Res Methodol; 2022 Mar; 22(1):64. PubMed ID: 35249528
[TBL] [Abstract] [Full Text] [Related]
11. Mechanistic Target of Rapamycin (mTOR) Inhibitors.
Wang D; Eisen HJ
Handb Exp Pharmacol; 2022; 272():53-72. PubMed ID: 35091825
[TBL] [Abstract] [Full Text] [Related]
12. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.
Herranz C; Mateo F; Baiges A; Ruiz de Garibay G; Junza A; Johnson SR; Miller S; García N; Capellades J; Gómez A; Vidal A; Palomero L; Espín R; Extremera AI; Blommaert E; Revilla-López E; Saez B; Gómez-Ollés S; Ancochea J; Valenzuela C; Alonso T; Ussetti P; Laporta R; Xaubet A; Rodríguez-Portal JA; Montes-Worboys A; Machahua C; Bordas J; Menendez JA; Cruzado JM; Guiteras R; Bontoux C; La Motta C; Noguera-Castells A; Mancino M; Lastra E; Rigo-Bonnin R; Perales JC; Viñals F; Lahiguera A; Zhang X; Cuadras D; van Moorsel CHM; van der Vis JJ; Quanjel MJR; Filippakis H; Hakem R; Gorrini C; Ferrer M; Ugun-Klusek A; Billett E; Radzikowska E; Casanova Á; Molina-Molina M; Roman A; Yanes O; Pujana MA
EMBO Mol Med; 2021 Sep; 13(9):e13929. PubMed ID: 34378323
[TBL] [Abstract] [Full Text] [Related]
13. Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience.
Revilla-López E; Berastegui C; Méndez A; Sáez-Giménez B; Ruiz de Miguel V; López-Meseguer M; Monforte V; Bravo C; Pujana MA; Ramon MA; Gómez-Ollés S; Roman A;
Sci Rep; 2021 May; 11(1):10171. PubMed ID: 33986388
[TBL] [Abstract] [Full Text] [Related]
14. Assessment of Conventional Solvent Extraction vs. Supercritical Fluid Extraction of Khella (
Khalil N; Bishr M; El-Degwy M; Abdelhady M; Amin M; Salama O
Molecules; 2021 Feb; 26(5):. PubMed ID: 33673560
[TBL] [Abstract] [Full Text] [Related]
15. Tissue Sodium Concentration Quantification at 7.0-T MRI as an Early Marker for Chemotherapy Response in breast cancer: A Feasibility Study.
Zaric O; Farr A; Minarikova L; Lachner S; Asseryanis E; Nagel AM; Weber M; Singer CF; Trattnig S
Radiology; 2021 Apr; 299(1):63-72. PubMed ID: 33591888
[TBL] [Abstract] [Full Text] [Related]
16. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With breast cancer or Ovarian cancer, 2012-2019.
Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
[TBL] [Abstract] [Full Text] [Related]
17. Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in breast cancer Patient-derived Xenografts.
Gris-Oliver A; Palafox M; Monserrat L; Brasó-Maristany F; Òdena A; Sánchez-Guixé M; Ibrahim YH; Villacampa G; Grueso J; Parés M; Guzmán M; Rodríguez O; Bruna A; Hirst CS; Barnicle A; de Bruin EC; Reddy A; Schiavon G; Arribas J; Mills GB; Caldas C; Dienstmann R; Prat A; Nuciforo P; Razavi P; Scaltriti M; Turner NC; Saura C; Davies BR; Oliveira M; Serra V
Clin Cancer Res; 2020 Jul; 26(14):3720-3731. PubMed ID: 32220884
[TBL] [Abstract] [Full Text] [Related]
18. The Fluoro-Thiazolylhydrazone Compound tsc-3C Inhibits Triple Negative breast cancer (TNBC) Cell Line Activity by Promoting Apoptosis, Regulating the MAPK Pathway and Inducing Mitochondrial Dysfunction.
Zhang J; Dai J; Zheng Q; Guo S; Yu Y; Hu W; Gao Y; Shi D
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033205
[TBL] [Abstract] [Full Text] [Related]
19. Synthesis of Cobalt Hydroxide Nano-flakes Functionalized with Glutamic Acid and Conjugated with Thiosemicarbazide for Anticancer Activities Against Human breast cancer Cells.
Bejarbaneh M; Moradi-Shoeili Z; Jalali A; Salehzadeh A
Biol Trace Elem Res; 2020 Nov; 198(1):98-108. PubMed ID: 31983053
[TBL] [Abstract] [Full Text] [Related]
20. Pharmacokinetics of Trastuzumab After Subcutaneous and Intravenous Administration in Obese Patients.
González García J; Gutiérrez Nicolás F; Ramos Díaz R; Nazco Casariego GJ; Viña Romero MM; Llabres Martinez M; Llanos Muñoz M; Batista López JN; Jiménez Sosa A; Ceballos Lenza I; Cruz Jurado J
Ann Pharmacother; 2020 Aug; 54(8):775-779. PubMed ID: 31971005
[No Abstract] [Full Text] [Related]
[Next]
